Efficacy of fluconazole therapy for cutaneous leishmaniasis. A case report and review of literature.
Keywords:
Cutaneous leishmaniasis, Fluconazole, Leishmania major, Sodium stibogluconate.Abstract
Cutaneous Leishmaniasis is endemic in the western province of Libya, including the Zliten countryside, despite its self-limited nature, many cases may run a chronic course and resist ordinary treatment, causing disfigurement or even deformity. Our case is a 47-year-old black Libyan man presented to us 2 years ago, with an ulcerated plaque in his left leg and infiltrated plaque in his right ear due to cutaneous leishmaniasis. While the leg ulcer healed with a small scar after a 6-week course of intra-lesional sodium stibogluconate, the lesion on the ear failed to heal by local treatment. Furthermore, parenteral antimony was stopped by a cardiologist. By time, nodules had developed inside the infiltrated lesion. After 18 months, the case was reevaluated by skin slit smear and histopathology, which both showed amastigotes in the lesion. We tried 150 mg of fluconazole daily for 45 days after appropriate investigations. Unfortunately, without success. Our paper details the clinical, parasitological and pathological findings of this case, in addition to literature review on the efficacy of oral fluconazole in treating cutaneous leishmaniasis
References
Nepal B, McCormick-Baw C, Patel K, Firmani S, Wetzel DM. Cutaneous Leishmania mexicana infections in the United States: defining strains through endemic human pediatric cases in northern Texas. Msphere. 2024:e00814-23.
Fischer T, Fischer M, Schliemann S, Elsner P. Treatment of mucocutaneous leishmaniasis–A systematic review. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 2024.
Francesconi VA, Francesconi F, Ramasawmy R, Romero GAS, Alecrim MdGC. Failure of fluconazole in treating cutaneous leishmaniasis caused by Leishmania guyanensis in the Brazilian Amazon: an open, nonrandomized phase 2 trial. PLoS Neglected Tropical Diseases. 2018;12(2):e0006225.
Michelerio A, Barruscotti S, Bossi G, Brazzelli V. Pediatric Old World cutaneous leishmaniasis treated with oral fluconazole: A case series. Pediatric Dermatology. 2018;35(3):384-7.
Benzaquen M, Chambelland A, Fongue J, Melenotte C, Christen JR, Ranque S, et al. Cutaneous sporotrichoid leishmaniasis treated with oral fluconazole. Dermatologic therapy. 2019;32(4).
Alrajhi AA, Ibrahim EA, De Vol EB, Khairat M, Faris RM, Maguire JH. Fluconazole for the treatment of cutaneous leishmaniasis caused by Leishmania major. New England Journal of Medicine. 2002;346(12):891-5.
Prates FVdO, Dourado ME, Silva SC, Schriefer A, Guimarães LH, Brito MdGO, et al. Fluconazole in the treatment of cutaneous leishmaniasis caused by Leishmania braziliensis: a randomized controlled trial. Clinical infectious diseases. 2016:ciw662.
Veraldi S, Romagnuolo M, Cusini M, Maronese CA. Therapy of cutaneous leishmaniasis caused by Leishmania braziliensis with fluconazole. Dermatologic Therapy. 2021;34(5):1-2.
Aoun K, Bouratbine A. Cutaneous leishmaniasis in North Africa: a review. Parasite. 2014;21.
Palumbo E. Current treatment for cutaneous leishmaniasis: a review. American journal of therapeutics. 2009;16(2):178-82.
Heras‐Mosteiro J, Monge‐Maillo B, Pinart M, Pereira PL, Garcia‐Carrasco E, Cuadrado PC, et al. Interventions for Old World cutaneous leishmaniasis. Cochrane Database of Systematic Reviews. 2017(11).
Wajihullah K, Zakai HA. Epidemiology, pathology and treatment of cutaneous leishmaniasis in Taif region of Saudi Arabia. Iranian journal of parasitology. 2014;9(3):365.
Khaled A, Goucha S, Trabelsi S, Zermani R, Fazaa B. Lupoid cutaneous leishmaniasis: a case report. Dermatology and therapy. 2011;1:36-41.
Sklavos AV, Walls T, Webber MT, Watson AB. Cutaneous leishmaniasis in a child treated with oral fluconazole. Australasian journal of dermatology. 2010;51(3):195-7.
Toubiana J, Armengaud J-B, Camet JD, Gendrel D. Oral fluconazole treatment for extensive cutaneous leishmaniasis in an 11-year-old child. The Pediatric infectious disease journal. 2006;25(11):1083-4.
Tan T, Yap N, Leong K, Teh C, Tay S, Lim Y. RESEARCH ARTICLE Imported case of Leishmania tropicacutaneous leishmaniasis in a 10-year-old child in Malaysia. Tropical Biomedicine. 2022;39(1):86-8.
Daly K, De Lima H, Kato H, Sordillo E, Convit J, Reyes‐Jaimes O, et al. Intermediate cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis successfully treated with fluconazole. Clinical and Experimental Dermatology. 2014;39(6):708-12.
Sousa AQ, Frutuoso MS, Moraes EA, Pearson RD, Pompeu MM. High-dose oral fluconazole therapy effective for cutaneous leishmaniasis due to Leishmania (Vianna) braziliensis. Clinical infectious diseases. 2011;53(7):693-5.
Yaich S, Charfeddine K, Masmoudi A, Masmoudi M, Zaghdhane S, Turki H, et al. Atypical presentation of cutaneous leishmaniasis in a renal transplant recipient successfully treated with allopurinol and fluconazole. Annals of Saudi Medicine. 2013;33(2):187-91.
Stewardson AJ, Leder K, Torresi J, Johnson DF. Two cases of Old World cutaneous leishmaniasis in Australian travelers visiting Morocco. Journal of travel medicine. 2010;17(4):278-80.
Chacko A, Joseph M, Feltis T, Morris SK. Case Report: Successful Treatment of Cutaneous Leishmaniasis with Topical Paramomycin in a Child after Treatment Failure with Systemic Fluconazole. The American journal of tropical medicine and hygiene. 2016;95(4):793.
Morizot G, Delgiudice P, Caumes E, Laffitte E, Marty P, Dupuy A, et al. Healing of Old World cutaneous leishmaniasis in travelers treated with fluconazole: drug effect or spontaneous evolution? American Journal of Tropical Medicine and Hygiene. 2007;76(1):48-52.
Parhizkar AR SM, Mansuri S, Hadibarhaghtalab M, Afrashteh S, Fatemian H, Chijan MR. . Comparing the efficacy of fluconazole and cryotherapy Versus cryotherapy alone on treating cutaneous leishmaniasis: a triple-blind randomized clinical trial. . BMC Infectious Diseases. 2024 20(1):332.
